Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-25 Purchase |
2023-09-27 7:46 pm |
Acasti Pharma Inc. | ACST | Kavuru Vimal Director 10% Owner |
676,371 | $1.848 | $1,249,934 | 1,735,152 (Indirect) |
View |
| 2023-08-31 Purchase |
2023-09-05 3:54 pm |
Acasti Pharma Inc. | ACST | Olds Donald Director |
381 | $2.05 | $781 | 1,173 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-14 Option Award |
2025-04-16 8:58 pm |
N/A 2035-04-14 |
Grace Therapeutics Inc. | GRCE | Kumar Amresh VP Program Management |
30,000 | $0 | 30,000 (Direct) |
View |
| 2025-04-14 Option Award |
2025-04-16 8:58 pm |
N/A 2035-04-14 |
Grace Therapeutics Inc. | GRCE | Macdonald R. Loch Chief Medical Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2025-04-14 Option Award |
2025-04-16 8:58 pm |
N/A 2035-04-14 |
Grace Therapeutics Inc. | GRCE | DelAversano Robert J Principal Financial Officer |
20,130 | $0 | 20,130 (Direct) |
View |
| 2025-04-14 Option Award |
2025-04-16 8:58 pm |
N/A 2035-04-14 |
Grace Therapeutics Inc. | GRCE | Kohli Prashant Chief Executive Officer |
225,400 | $0 | 225,400 (Direct) |
View |
| 2025-04-14 Option Award |
2025-04-16 8:58 pm |
N/A 2035-04-14 |
Grace Therapeutics Inc. | GRCE | D'Andrea Carrie VP Clinical Operations |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership(A) |
2024-07-11 11:16 am |
N/A N/A |
Acasti Pharma Inc. | ACST | ADAR1 Capital Management LLC ADAR1 Partners LP 10% Owner |
0 | $0 | 3,141,397 (Indirect) |
View |
Ownership |
2024-07-09 8:29 pm |
N/A N/A |
Acasti Pharma Inc. | ACST | ADAR1 Capital Management LLC ADAR1 Partners LP 10% Owner |
0 | $0 | 959,571 (Indirect) |
View |
| 2024-05-06 Option Award(A) |
2024-05-10 4:11 pm |
N/A 2034-05-06 |
Acasti Pharma Inc. | ACST | D'Andrea Carrie VP Clinical Operations |
19,740 | $0 | 19,740 (Direct) |
View |
| 2024-05-06 Option Award(A) |
2024-05-10 4:07 pm |
N/A 2034-05-06 |
Acasti Pharma Inc. | ACST | Kumar Amresh VP Program Management |
19,740 | $0 | 19,740 (Direct) |
View |
| 2024-05-06 Option Award |
2024-05-08 7:19 pm |
N/A 2034-05-06 |
Acasti Pharma Inc. | ACST | D'Andrea Carrie VP Program Management |
19,740 | $0 | 19,740 (Direct) |
View |
| 2024-05-06 Option Award |
2024-05-08 7:19 pm |
N/A 2034-05-06 |
Acasti Pharma Inc. | ACST | Kumar Amresh VP Clinical Operations |
19,740 | $0 | 19,740 (Direct) |
View |
| 2024-05-06 Option Award |
2024-05-08 7:19 pm |
N/A 2034-05-06 |
Acasti Pharma Inc. | ACST | Macdonald R. Loch Chief Medical Officer |
25,380 | $0 | 25,380 (Direct) |
View |
| 2024-05-06 Option Award |
2024-05-08 7:18 pm |
N/A 2034-05-06 |
Acasti Pharma Inc. | ACST | DelAversano Robert J Principal Financial Officer |
4,500 | $0 | 4,500 (Direct) |
View |
| 2024-05-06 Option Award |
2024-05-08 7:18 pm |
N/A 2034-05-06 |
Acasti Pharma Inc. | ACST | Kohli Prashant Chief Executive Officer |
128,770 | $0 | 128,770 (Direct) |
View |
Ownership |
2024-01-08 08:00 am |
N/A 2033-12-19 |
Acasti Pharma Inc. | ACST | DelAversano Robert J Vice President, Finance |
0 | $0 | 42,000 (Direct) |
View |
| 2023-12-19 Option Award |
2023-12-20 4:08 pm |
N/A 2033-12-19 |
Acasti Pharma Inc. | ACST | Kavuru Vimal Director 10% Owner |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-12-19 Option Award |
2023-12-20 4:08 pm |
N/A 2033-12-19 |
Acasti Pharma Inc. | ACST | Kottayil George Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2023-12-19 Option Award |
2023-12-20 4:06 pm |
N/A 2033-12-19 |
Acasti Pharma Inc. | ACST | NEUGEBOREN EDWARD Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2023-12-19 Option Award |
2023-12-20 4:06 pm |
N/A 2033-12-19 |
Acasti Pharma Inc. | ACST | DAVIS A BRIAN Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2023-12-19 Option Award |
2023-12-20 4:05 pm |
N/A 2033-12-19 |
Acasti Pharma Inc. | ACST | Kohli Prashant Chief Executive Officer |
41,668 | $0 | 41,668 (Direct) |
View |
Ownership |
2023-10-20 12:23 pm |
N/A N/A |
Acasti Pharma Inc. | ACST | Kottayil George Director |
0 | $0 | 494,698 (Direct) |
View |
Ownership |
2023-10-20 12:22 pm |
N/A N/A |
Acasti Pharma Inc. | ACST | NEUGEBOREN EDWARD Director |
0 | $0 | 37,895 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 4:37 pm |
N/A 2033-07-14 |
Acasti Pharma Inc. | ACST | Derby Michael Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 4:36 pm |
N/A 2033-07-14 |
Acasti Pharma Inc. | ACST | Kavuru Vimal Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 4:36 pm |
N/A 2033-07-14 |
Acasti Pharma Inc. | ACST | Olds Donald Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 4:34 pm |
N/A 2033-07-14 |
Acasti Pharma Inc. | ACST | Macdonald R. Loch Chief Medical Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 4:32 pm |
N/A 2033-07-14 |
Acasti Pharma Inc. | ACST | D'Andrea Carrie VP Clinical Operations |
42,000 | $0 | 42,000 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 4:28 pm |
N/A 2033-07-14 |
Acasti Pharma Inc. | ACST | Kumar Amresh VP Program Management |
42,000 | $0 | 42,000 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 4:26 pm |
N/A 2033-07-14 |
Acasti Pharma Inc. | ACST | Kohli Prashant Chief Executive Officer |
208,334 | $0 | 208,334 (Direct) |
View |
Ownership |
2023-05-18 3:57 pm |
N/A N/A |
Acasti Pharma Inc. | ACST | Kumar Amresh VP Program Management |
0 | $0 | 66,712 (Direct) |
View |
| 2022-09-28 Option Award |
2022-09-30 4:21 pm |
N/A 2032-09-28 |
Acasti Pharma Inc. | ACST | Kavuru Vimal Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-09-28 Option Award |
2022-09-30 4:20 pm |
N/A 2032-09-28 |
Acasti Pharma Inc. | ACST | Olds Donald Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-09-28 Option Award |
2022-09-30 4:19 pm |
N/A 2032-09-28 |
Acasti Pharma Inc. | ACST | Canan John Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-09-28 Option Award |
2022-09-30 4:18 pm |
N/A 2032-09-28 |
Acasti Pharma Inc. | ACST | Derby Michael Director |
85,000 | $0 | 85,000 (Direct) |
View |
Ownership |
2022-09-16 4:18 pm |
N/A N/A |
Acasti Pharma Inc. | ACST | Kohli Prashant CCO |
0 | $0 | 327,238 (Direct) |
View |